Company Filing History:
1 out of 1 
1 out of 92 
Years Active: 2018
Title: Janet Karpinski: Innovator in Retroviral Research
Introduction
Janet Karpinski is a distinguished inventor based in Dresden, Germany. She has made significant contributions to the field of virology, particularly in the development of tailored recombinases for retroviral applications. Her innovative work focuses on methods that can potentially transform the treatment and prevention of retrovirus infections, including HIV.
Latest Patents
Karpinski holds a patent for a "Well-tolerated and highly specific tailored recombinase for recombining asymmetric target sites in a plurality of retrovirus strains." This invention relates to a method for preparing an expression vector that encodes a tailored recombinase capable of recombining asymmetric target sequences within the long terminal repeat (LTR) of proviral DNA. The recombinase is designed to target a variety of retrovirus strains, making it a valuable tool in the fight against retroviral infections. The pharmaceutical compositions derived from this invention are particularly useful in the treatment and prevention of HIV infection.
Career Highlights
Throughout her career, Karpinski has worked with notable institutions, including the Heinrich-Pette-Institut Leibniz-Institut für Experimentelle Virologie and Technische Universität Dresden. Her research has been pivotal in advancing our understanding of retroviral mechanisms and developing innovative therapeutic strategies.
Collaborations
Karpinski has collaborated with esteemed colleagues such as Joachim Hauber and Jan Chemnitz. These partnerships have further enriched her research and contributed to the success of her innovative projects.
Conclusion
Janet Karpinski's work exemplifies the intersection of innovation and science in the field of virology. Her contributions are paving the way for new therapeutic approaches to combat retroviral infections, particularly HIV.